Monoclonal antibody demand in Tennessee and southern states with low COVID-19 vaccination rates led the Biden administration to limit drug supplies.
Source: The Daily News
Tennessee may run low on monoclonal antibodies that treat COVID-19 as feds cap shipments to protect supply